Search results
Results from the Tech24 Deals Content Network
Bisacodyl is an organic compound that is used as a stimulant laxative drug. It works directly on the colon to produce a bowel movement. It is typically prescribed for relief of episodic and chronic constipation and for the management of neurogenic bowel dysfunction, as well as part of bowel preparation before medical examinations, such as for a colonoscopy.
The Medicaid Drug Rebate Program is a program in the United States that was created by the Omnibus Budget Reconciliation Act of 1990 (OBRA'90). The program establishes mandatory rebates that drug manufacturers must pay state Medicaid agencies related to the dispensing of outpatient prescription drugs covered by Medicaid .
Dulcolax. Dulcolax may refer to: Dulcolax, a trade name of bisacodyl, a stimulant laxative drug that increases bowel movement. Dulcolax Balance, a trade name of macrogol, an osmotic laxative. Dulcolax Stool Softener, a trade name of dioctyl sodium sulfosuccinate, a common ingredient in products such as laxatives. Dulcolax SP Drops, a trade name ...
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
The hack occurred in April on a third-party cloud platform, AT&T said, and impacted people who were customers from May 1, 2022 to Oct. 31, 2022, as well as on Jan. 2, 2023. The data shows other ...
June 20, 2024 at 1:25 PM. (Reuters) - The World Health Organization on Thursday issued warnings on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug ...
Signed into law by President George H. W. Bush on October 29, 1992. The Prescription Drug User Fee Act ( PDUFA) was a law passed by the United States Congress in 1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process. The Act provided that the FDA was entitled to ...
Enrollment in the ACA marketplace for this year hit a record high 21 million, including 5.2 million first-time enrollees, according to the KFF, a health policy and research organization.